Retinal toxicity of recombinant tissue plasminogen activator in the rabbit

M. W. Johnson, K. R. Olsen, E. Hernandez, W. D. Irvine and R. N. Johnson
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, FL 33101.

We studied the dose-dependent retinal toxicity of the available commercial preparation of human recombinant tissue plasminogen activator in the normal rabbit eye. Tissue plasminogen activator was injected into the midvitreous cavity of albino rabbits in doses (per 100 microL) of 25, 50, 75, and 100 micrograms. Control eyes received 100 microL of balanced salt solution or tissue plasminogen activator vehicle. No evidence of a retinal toxic reaction was seen in eyes receiving 25 micrograms of tissue plasminogen activator. One of four eyes injected with 50 micrograms showed loss of photoreceptor cells by light microscopy. Severe retinal damage was seen by ophthalmoscopy, electroretinography, and light microscopy in three of four eyes receiving 75 micrograms of tissue plasminogen activator and in all eyes treated with 100 micrograms of tissue plasminogen activator or equivalent vehicle. These results suggest that the commercial recombinant tissue plasminogen activator formulation has a narrow margin of safety in nonvitrectomized eyes and that a component of the vehicle is the toxic factor.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Toxic Effects of Recombinant Tissue Plasminogen Activator on Cultured Human Corneal Endothelial Cells
Yoeruek et al.
IOVS 2008;49:1392-1397.
ABSTRACT | FULL TEXT  

Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage
Oshima et al.
Br. J. Ophthalmol. 2007;91:193-198.
ABSTRACT | FULL TEXT  

Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion
Mahmoud et al.
Br. J. Ophthalmol. 2006;90:911-915.
ABSTRACT | FULL TEXT  

A study of retinal penetration of intravitreal tenecteplase in pigs.
Kwan et al.
IOVS 2006;47:2662-2667.
ABSTRACT | FULL TEXT  

Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.
Singh et al.
Br. J. Ophthalmol. 2006;90:429-431.
ABSTRACT | FULL TEXT  

Intravitreal Injection of Tissue Plasminogen Activator: Four Considerations
Hesse and Johnson
Arch Ophthalmol 2001;119:456-457.
FULL TEXT  

Recombinant tissue plasminogen activator following paediatric cataract surgery
Mehta and Adams
Br. J. Ophthalmol. 2000;84:983-986.
ABSTRACT | FULL TEXT  

Nonsurgical Management of Macular Hemorrhage Secondary to Retinal Artery Macroaneurysms
McCabe et al.
Arch Ophthalmol 2000;118:780-785.
ABSTRACT | FULL TEXT  

Retinal Toxicity of Commercial Intravitreal Tissue Plasminogen Activator Solution in Cat Eyes
Hrach et al.
Arch Ophthalmol 2000;118:659-663.
ABSTRACT | FULL TEXT  

Pneumatic Displacement of Subretinal Hemorrhage Without Tissue Plasminogen Activator
Ohji et al.
Arch Ophthalmol 1998;116:1326-1332.
ABSTRACT | FULL TEXT